Speed Your Orphan Drug to Clinic and Market

In Market Access by Freya Smale

Pills1Accelerated Orphan Development. Integrated Solutions.

OptiPact™ Technology is Catalent’s technology that provides you a single source solution for oral solid formulations by offering integrated development, analytical, clinical and commercial roller compaction continuous manufacturing and packaging at ONE facility to get your product to clinic and to market faster.

Why choose Optipact:

  • Scalability, continuous manufacturing process for going from clinical batches into commercial production
  • Flexibility to accommodate a wide range of API characteristics
  • Integrated development, analytical, clinical, commercial manufacturing and packaging
  • One partner at one site to maximize the efficiency

Download a recent expert webinar Applications of Integrated Solutions in Accelerated Drug Development Programs. Watch the webinar and hear from Catalent experts on how an integrated development approach can be used to mitigate risk and reduce timelines to get maximum benefit from receiving expedited or orphan regulatory designation for your drug.